Results 201 to 210 of about 1,471,209 (258)

Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR). [PDF]

Clin Transl Allergy
Cavaliere C, Seys SF, de Kinderen J, Bettio G, Andrianakis A, Alobid I, Hellings PW, Van Gerven L, Hox V, Hopkins C, Kjeldsen A, Reitsma S, Schneider S, Tomazic PV, Diamant Z, Eckl-Dorna J, Fokkens WJ, Holzmeister C, Larsen K, Laulajainen-Hongisto A, Loperfido A, Lund V, Mariën G, Masieri S, Mortuaire G, Moyaert M, Mullol J, Otten J, Rodriquez-Van Strahlen C, Wagenmann M, Bachert C.   +30 more
europepmc   +1 more source

Optimizing photoactivation of PA‐mCherry for optical pooled CRISPR screens

FEBS Open Bio, EarlyView.
Photoactivatable PA‐mCherry finds widespread use to optically tag individual cells. However, confocal 405 nm UV laser‐scanning (normal scan) is much less efficient than widefield UV illumination, limiting the use of PA‐mCherry on confocal instruments. We remedy this limitation by reporting that rapid and repeated confocal scanning with a low‐intensity,
Sravasti Mukherjee, Giulia Zanetti, Bram van den Broek, Kees Jalink   +3 more
wiley   +1 more source

Diagnosing Type 2 Inflammation in COPD: Comparison of Blood and Sputum Eosinophil Assessment in the University of California Los Angeles COPD Phenotyping Study. [PDF]

Chronic Obstr Pulm Dis
LeMaster WB, Ingersoll SA, Phee H, Wen R, Bai J, Belperio JA, Buhr RG, Phillips JE, Palchevskiy V, Bina T, Tashkin DP, Cooper CB, Barjaktarevic IZ.   +12 more
europepmc   +1 more source

Refinement of amino‐acid conformation vs. difference density maps in time‐resolved serial femtosecond crystallography data analysis

FEBS Open Bio, EarlyView.
The dFoCC pipeline starts with observed DED and resting‐state coordinates, which are then used to generate a library of triggered states. Correlation analysis of the calculated DED features of each candidate vs observed DED permits quantitative evaluation of candidate structural quality.
Meng Iao Fong, Yuhei Hosokawa, Lars Oliver Essen, Manuel Maestre‐Reyna   +3 more
wiley   +1 more source

Type 2 inflammation: A unifying pathway in allergic diseases and a call to action for the Allergist-Immunologist. [PDF]

Allergy Asthma Proc
Bellanti JA, Settipane RA.
europepmc   +1 more source

Acute caffeine treatment protects the developing retina from ischemia‐induced cell death

FEBS Open Bio, EarlyView.
Caffeine reduces cell death in the developing retina under ischemia (OGD). This effect does not involve BDNF upregulation or antioxidant pathways (NRF2/VEGF). Neuroprotection occurs mainly through adenosine A2A receptor antagonism, decreasing glutamate release and excitotoxicity, highlighting caffeine's potential as an acute neuroprotective agent in ...
Amanda Alves Nascimento, Danniel Pereira‐Figueiredo, Gabriella Grossi de Lima Dias, Gabriel Ferreira dos Santos, Mariana Rodrigues Pereira, Rafael Brito, Karin C Calaza   +6 more
wiley   +1 more source

Bronchial thermoplasty reduces asthma exacerbation and improves quality of life in asthma with type 2 inflammation. [PDF]

J Thorac Dis
Angsuwatcharakorn T, Savigamin C, Thanthitaweewat V, Leelayuwatanakul N, Kawkitinarong K, Thawanaphong S, Wongkarnjana A, Jaimchariyatam N, Jirakran K, Sittipunt C, Sriprasart T.   +10 more
europepmc   +1 more source

Systemic barrier dysfunction in type 2 inflammation diseases: perspective in the skin, airways, and gastrointestinal tract. [PDF]

Immunol Res
Meng J, Xiao H, Xu F, She X, Liu C, Canonica GW.   +5 more
europepmc   +1 more source

Prevalence, Change and Burden of Systemic Corticosteroid Use in Type 2 Inflammation Associated Diseases Over 25 Years - A Nationwide Danish Study. [PDF]

J Asthma Allergy
Håkansson KEJ, Skov IR, Andersen SAW, Ali Z, Løkke A, Ibsen R, Hilberg O, Meteran H, Johnsen CR, Backer V, Ulrik CS.   +10 more
europepmc   +1 more source

Type-2 Inflammation in Health and Disease: Prevalence, Risk Factors and Multimorbidity. [PDF]

J Clin Med
Lim CJM, Gross C, Breyer MK, Breyer-Kohansal R, Wouters EFM, Hartl S.   +5 more
europepmc   +1 more source